Abstract
Pathological aggregation of the transactive response DNA-binding protein of 43 kDa (TDP-43) is associated with several neurodegenerative disorders, including ALS, frontotemporal dementia, chronic traumatic encephalopathy, and Alzheimer's disease. TDP-43 aggregation appears to be largely driven by its low-complexity domain (LCD), which also has a high propensity to undergo liquid–liquid phase separation (LLPS). However, the mechanism of TDP-43 LCD pathological aggregation and, most importantly, the relationship between the aggregation process and LLPS remains largely unknown. Here, we show that amyloid formation by the LCD is controlled by electrostatic repulsion. We also demonstrate that the liquid droplet environment strongly accelerates LCD fibrillation and that its aggregation under LLPS conditions involves several distinct events, culminating in rapid assembly of fibrillar aggregates that emanate from within mature liquid droplets. These combined results strongly suggest that LLPS may play a major role in pathological TDP-43 aggregation, contributing to pathogenesis in neurodegenerative diseases.
Keywords: TAR DNA-binding protein 43 (TDP-43) (TARDBP), amyloid, protein aggregation, intrinsically disordered protein, amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease), neurodegeneration, fibrillation, liquid-liquid phase separation
Introduction
Proteinaceous inclusions containing the transactive response DNA-binding protein of 43 kDa (TDP-43)3 are a pathological hallmark of sporadic ALS (1, 2) and are observed in numerous other neurodegenerative disorders associated with protein misfolding, including frontotemporal lobar degeneration with ubiquitin-positive inclusions (1, 3), Alzheimer's disease (4–6), chronic traumatic encephalopathy (7), and cerebral age-related TDP-43 with sclerosis (8). Such a widespread observation of TDP-43 pathology underscores the need to gain molecular-level insight into the aggregation pathway(s) of the protein, as this may be critical to understanding the underlying disease pathogenesis and to developing therapies.
TDP-43 consists of an N-terminal Dix-like domain (9) that mediates self-assembly (10), two RNA-recognition motifs, and an intrinsically disordered low-complexity domain (LCD) at the C terminus (11–13). An important feature of TDP-43 inclusions is the differential involvement of C-terminal fragments (CTFs), which are enriched in hippocampal preparations from patients (14). Studies have proposed a caspase-mediated cleavage event resulting in the robust production of CTFs of various sizes (25 and 35 kDa) (1, 15, 16). Invariably, these CTFs contain the glycine-rich, disordered LCD (residues ∼267–414) that appears to be of key importance to the intrinsic aggregation propensity of TDP-43 (12). Recent studies indicate, however, that the N-terminal domain is also important, playing a regulatory role in the formation of different types of aggregates (17). Even though the specific nature of TDP-43 aggregates from patient histopathological samples is a topic for discussion (1, 18–20), the prion-like progressive behavior of TDP-43 proteinopathies (21–24) suggests that these aggregates have a seeding capacity characteristic of amyloids. Consistent with this notion, recent studies have revealed that the isolated LCD (13) and many of its fragments (25–31) readily form amyloid fibrils, whereas deletion of or within this region abrogates fibrillation (32–34). However, little is known about the mechanism of this amyloidogenic pathway.
The picture is further complicated by recent findings that, under certain experimental conditions, the TDP-43 LCD undergoes liquid–liquid phase separation (LLPS) whereby hydrophobic interactions and charge screening (35–38) facilitate assembly of reversible, liquid-like droplets. These dynamic species may subsequently convert to static assemblies (10, 35). For some other proteins that form liquid droplets, such as Fused in sarcoma (FUS) (39) and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) (40, 41), aging of droplets was reported to eventually lead to the formation of amyloid fibrils. However, the impact of LLPS on the aggregation pathway of TDP-43 remains unexplored.
In this report, we describe biophysical studies on the relationship between LLPS of the TDP-43 LCD and its aggregation properties. The key finding of these studies is that LLPS conditions per se strongly promote TDP-43 amyloid fibril formation and that self-assembly of the protein is heavily regulated by electrostatic effects. These observations in vitro provide a foundation for understanding the role of LLPS in the formation in vivo of pathological TDP-43 aggregates within the context of neurodegenerative diseases.
Results
Conditions promoting liquid–liquid phase separation of the TDP-43 LCD
To systematically investigate the role of LLPS in pathological aggregation of the TDP-43 LCD, we began by characterizing its phase separation behavior under experimental conditions to be tested in this study. We utilized turbidity measurements (optical density at 600 nm) as a primary tool to delineate the liquid–liquid phase boundary of the TDP-43 LCD. Because both TDP-43 aggregation (12) and LLPS (35, 36) can result in observable turbidity, sole formation of liquid droplets was confirmed by optical microscopy. Similar to other reports (35, 36) that used buffer with pH around 6, we found that under these conditions the presence of salt induced LLPS for our protein. Significant droplet formation was observed by using Alexa Fluor 488–labeled protein at ∼150 mm NaCl, with a considerable increase in turbidity at higher salt concentrations (Fig. 1, A and B).
Figure 1.
Liquid–liquid phase separation of the TDP-43 LCD. A, representative fluorescence microscopy images of 20 μm LCD at pH 4, 6, and 7 with varying salt concentrations at 25 °C using a 200:1 ratio of unlabeled to Alexa Fluor 488–labeled protein. B, LLPS of TDP-43 LCD as monitored by turbidity (A600) at varying pH and salt concentrations, 25 °C. Protein concentration, 20 μm. C, LLPS as monitored by turbidity at decreasing protein concentrations in the presence of varying amounts of salt. Buffer conditions, 10 mm potassium phosphate, pH 6. D, turbidity as a measure of LLPS at 25 and 37 °C with increasing salt concentrations. Protein concentration, 20 μm; buffer conditions, 10 mm potassium phosphate, pH 6. E, turbidity measured with increasing concentration of PEG-10,000 and various concentrations of NaCl. Protein concentration, 20 μm; buffer conditions, 10 mm potassium phosphate, pH 6, 25 °C. F, LLPS as monitored by turbidity as a function of protein concentration. Buffer conditions, 10 mm potassium phosphate, pH 7.3, 150 mm NaCl, 10% PEG-10,000, 37 °C. G, representative bright-field images corresponding to conditions described in F. Scale bar, 5 μm. H, LLPS as monitored by turbidity as a function of protein concentration. Buffer conditions, 10 mm potassium phosphate, pH 7.3, 150 mm KCl, 10% PEG-10,000, 37 °C, with and without 1 mm DTT. I, representative bright-field images corresponding to conditions in H. Scale bar, 5 μm. Error bars represent S.D.
Peculiarly, previous studies on the LLPS of the TDP-43 LCD focused almost exclusively on experimentation around pH 6–6.5 (35, 36). To explore in greater detail the effect of environmental conditions on the phase behavior of the protein, we performed additional experiments under different buffer conditions. We found that the propensity of the TDP-43 LCD to undergo LLPS is strongly pH-dependent, requiring higher salt concentrations as pH is decreased (Fig. 1B). Importantly, at neutral pH, a small degree of LLPS was observed even in the absence of salt (Fig. 1A). Under all conditions, we consistently observed the promotion of LLPS by the presence of salt, with the threshold NaCl concentration for droplet formation increasing with a decreasing pH (Fig. 1B). Similarly, lower protein concentrations required higher salt concentrations to observe an increased turbidity (Fig. 1C).
Consistent with previous observations (35), we also found that temperature elevation to 37 °C at pH 6 resulted in no detectable turbidity of protein solution in the presence of up to 200 mm NaCl (Fig. 1D). This raised questions whether physiologically relevant conditions are indeed conducive to LLPS of TDP-43. To address this conundrum, we sought to emulate the crowded intracellular environment through the addition of the volume-excluding polymer PEG (42). We found that the addition of PEG at typical concentrations used to mimic cellular crowding (43) resulted in LLPS at lower salt concentrations (25–50 mm) or even in the absence of salt at pH 6, conditions that are not conducive to LLPS when PEG is not present (Fig. 1E). Thus, crowding effects and charge screening appear to work in concert to facilitate LLPS.
With the observations that neutral pH, salt, and crowding agent all facilitate LLPS, we tested whether LLPS readily occurs under physiologically relevant conditions (pH 7.3, 150 mm NaCl, 37 °C, 10% PEG). Under these conditions, we observed a small but significant change in turbidity between 2 and 5 μm protein concentrations (and becoming much larger at higher concentrations) (Fig. 1F). Furthermore, spherical droplets were identifiable by microscopy, even though at the lowest protein concentrations these species were relatively small, with a diameter below 1 μm (Fig. 1G). Further confirming the physiological relevance of LLPS, we also found that droplets could be detected using low protein concentrations at pH 7.3, in the presence of 150 mm KCl, with or without 1 mm DTT (to mimic the environment of the nucleoplasm or cytoplasm, respectively) (Fig. 1, H and I). Overall, these results demonstrate that physiologically relevant conditions are potentially conducive to TDP-43 LCD LLPS, providing a rationale for exploring the role of LLPS in pathological aggregation of the protein.
Salt promotes rapid self-association of TDP-43 LCD into oligomers
The above results demonstrated that LLPS of the TDP-43 LCD can be readily manipulated by experimental conditions and provided a foundation to explore biophysical and structural properties of the protein in relation to LLPS. Previous solution NMR studies (35, 36) of the LCD have revealed a partially α-helical region between residues ∼320 and 340, which is proposed to mediate self-association of the protein into dimers, or possibly even larger multimers, as well as contribute to LLPS. However, the use of solution NMR to study protein liquid–liquid phase separation is not without limitations, as larger species may be undetectable (36). Here, we used a complementary tool for structural study, site-directed spin labeling (SDSL) coupled with electron paramagnetic resonance (EPR) spectroscopy. The advantage of this approach is that EPR spectra are highly sensitive to local motions of a paramagnetic spin label attached to individual side chains, providing site-specific information about dynamics of all protein states within a sample (i.e. monomers, small multimers, and large aggregates), both in bulk solution and the phase-separated state. To facilitate these studies, we developed a library of spin-labeled variants of the TDP-43 LCD. Our library emphasized residues within the previously identified α-helical region (13, 30, 35) as these residues were the most likely candidates to be involved in potential conformational changes and intermolecular interfaces. All spin-labeled variants described in our study were confirmed to not significantly alter the LLPS propensity of the LCD (Fig. S1). Because LLPS is strongly modulated by intermolecular interactions between the helices of LCD molecules (35), this suggests that the Cys variants used largely retained helical assembly capability; however, this was not directly ascertained.
In the absence of salt, EPR spectra of all variants tested (both at pH 6 and 4) depicted three relatively sharp lines, as illustrated in Fig. 2A for protein labeled at either position 280 or 333. Spectra of this type are characteristic of a highly dynamic (mobile) nitroxide label with a rotational correlation time on the order of 10−9 s (44). However, the amplitudes of spin-normalized spectra for labels at different positions show some variability, suggesting site-specific differences in mobility. Therefore, for more quantitative insight into residue mobility throughout the protein, we calculated for each spectrum the inverse of the width of the central line (ΔH0−1), a frequently used EPR mobility parameter (45). Even though ΔH0−1 values for all residues tested are in a range that is characteristic of high mobility (46), the motion appears somewhat more restricted (smaller ΔH0−1) for residues within the ∼323–337 region as compared with residues outside this region (Fig. 2B). This is consistent with NMR data detecting partial α-helical structure at pH ∼6 within this region (13, 30, 35, 36). Furthermore, the present EPR data, together with the similarity of CD spectra at pH 6 and 4 (Fig. S2A), suggest that the propensity for these residues to form an α-helix is preserved under acidic conditions.
Figure 2.
Rapid oligomerization of TDP-43 in the context of LLPS. A, representative EPR spectra of TDP-43 LCD (20 μm) spin-labeled at position 280 (black) and 333 (red). Spectra were recorded at pH 4 in the absence of NaCl. B, the mobility parameter (inverse of the central line width, ΔH0−1) for residues probed by SDSL at pH 4 and 6, both in the absence of NaCl. C, spin-normalized EPR spectra for TDP-43 LCD labeled at residue 327 at 0 (black) and 150 mm NaCl (blue). Protein concentration, 20 μm. D, scaling of spectra shown in C to the same intensity of the central line clearly reveals the appearance in the presence of 150 mm NaCl of a second, broad component with intensity, I2, that is distinct from the first, sharp component with intensity, I1. Inset, the second component can be even better visualized via spectral subtraction of the first component. E, intensity ratios (I2/I1) of the broad-to-sharp components (as defined in D) for residues probed by SDSL in the absence (gray) and presence of 150 mm NaCl (blue) at pH 6 (left; LLPS was observed in the presence of salt) and pH 4 (right; no LLPS under either condition). F, size distribution of TDP-43 LCD at pH 4 with and without 150 mm NaCl. Protein concentrations, 100 μm at 25 °C.
Upon the addition of salt at pH 6 to induce LLPS, we immediately observed major changes in EPR spectra for some spin-labeled variants of TDP-43 LCD (all measurements were performed within 10 min of sample preparation). As exemplified in Fig. 2, C and D, for the protein labeled at residue 327, these changes were characterized by diminished intensity of the spectral amplitude in spin-normalized spectra (Fig. 2C) and the appearance of a second, broad spectral component that was most readily identifiable upon spectral scaling to the same amplitude of the central line (Fig. 2D) or after subtraction of the sharp component (Fig. 2D, inset). The appearance of the latter component clearly indicates the presence of a second population of protein molecules, in which the specific amino acid residue is more greatly immobilized, with rotational motions in the 10−8–10−7-s timescale (44). The relative prevalence of this immobilized population can be assessed by calculating the ratio of peak intensities, I2/I1, for the broad and sharp spectral components as shown in Fig. 2D. Using this parameter, a residue-specific profile was developed for pH 6, 150 mm NaCl LLPS conditions and compared with that for the conditions with no LLPS (pH 6, 0 mm NaCl) (Fig. 2E). This profile indicates that the appearance of an immobilized component observed under LLPS conditions is largely limited to residues within the previously identified α-helical region, with some residues having a greater second component contribution than others (the non-zero intensity ratios in the absence of salt (Fig. 2E, gray bars) are due to a small contribution in this part of the spectrum from the mobile component).
In principle, the broad component observed in EPR spectra at pH 6 in the presence of salt (i.e. LLPS conditions) could potentially reflect folding of TDP-43 LCD monomers in such a way that specific residues become immobilized due to strong tertiary interactions. However, given previous NMR data (36), this scenario is unlikely. Other possibilities are that this immobilization results from rapid oligomerization of the protein, with the immobilized residues being involved in intermolecular interfaces, or that transient intermolecular interactions under LLPS conditions differentially alter the mobility of specific residues.
To further explore the latter two possibilities and test whether the presence of a residue-specific immobilized component at pH 6 in the presence of 150 mm NaCl is exclusively related to LLPS, we took advantage of the observation that the addition of moderate concentrations of salt (150 mm NaCl) at pH 4 results in oligomerization of the protein without inducing LLPS. As shown in Fig. 2F, this oligomerization reaction was clearly demonstrated by dynamic light scattering measurements (which could not be performed upon droplet formation at pH 6 due to severe light scattering). At pH 4 in the absence of NaCl, the TDP-43 LCD exists as a single species with a hydrodynamic radius (rH) of ∼2.1 nm and a predicted molecular mass of 16.8–18.6 kDa, strongly indicative of a monomeric nature. However, the addition of salt resulted in a clear bimodal distribution, with the smaller species likely corresponding to relatively small multimers, (rH = 2.7 ± 0.7 nm; predicted average molecular mass of 38.5 ± 22.8 kDa) and the larger species corresponding to much larger oligomers (rH = 13.8 ± 3.5 nm). This larger species was estimated to represent ∼64% of the total protein mass but was unlikely to be related to liquid droplet formation as no turbidity was observed and no droplet-like species were detected by microscopy at these conditions (Fig. 1, A and B).
Importantly, the addition of 150 mm NaCl at pH 4 resulted in the appearance in EPR spectra of the second, immobilized component exclusively for residues within the ∼325–335 region, with the peak intensity ratio profile qualitatively similar to that described above for LLPS conditions at pH 6 (Fig. 2E). In light of similar spectral changes being observed under both LLPS and non-LLPS (oligomer-forming) conditions, we reasoned that these findings would more likely reflect oligomer-specific interactions rather than more transient intermolecular interactions solely inherent to LLPS. However, due to large light scattering on liquid droplets, direct detection of oligomers under LLPS conditions was not possible. To ascertain whether oligomerization might also involve changes in secondary structure, CD spectra at pH 4 were recorded and found to be very similar in the presence and absence of salt (Fig. S2B). This further indicated that salt-induced changes in EPR spectra are largely (if not solely) due to protein self-association. Collectively, these data indicate that (i) salt induces rapid oligomerization of TDP-43 LCD in the absence of LLPS, with similar oligomerization possibly also occurring under the conditions of LLPS, and (ii) oligomerization interfaces appear to be limited to residues within the α-helical region.
TDP-43 fibrillation in the absence of liquid–liquid phase separation
Previous studies report that the TDP-43 LCD or its fragments can form amyloid fibrils (13, 25, 26, 28, 29). However, the mechanistic aspects of this reaction remain poorly understood. Limited studies addressing this issue using a longer C-terminal fragment construct were performed in a buffer containing 2.5 m urea, making interpretation of these data difficult (47). Even more important, no information is available regarding the relationship between fibril formation and LLPS of the TDP-43 LCD.
To build a foundation for understanding the role of LLPS in TDP-43 LCD amyloid formation, we first studied fibrillation kinetics in the absence of LLPS. We found that incubation of the LCD at pH 6 in the absence of salt resulted in formation of fibrillar aggregates. Atomic force microscopy (AFM) imaging depicted these as nonclumped, well-dispersed fibers of ∼5–10 nm in height (Fig. 3A). These aggregates exhibited a strong Thioflavin-T (ThT) fluorescence, suggesting a cross-β structure consistent with fiber diffraction reports (48) and allowing the monitoring of the kinetics of fibril formation via ThT fluorescence assay (Fig. 3B). These traces indicated classical fibrillation kinetics, with identifiable initial lag phase (corresponding to nucleus formation) followed by the fibril growth (elongation) phase (49). Consistent with observations for other amyloidogenic proteins (50, 51), the lag time duration was related to the concentration of protein, with higher concentrations promoting more rapid fibrillation (Fig. 3C).
Figure 3.
TDP-43 LCD fibrillation in the absence of LLPS. A, atomic force microscopy image of fibrillar aggregates formed from 20 μm protein in the absence of NaCl at 25 °C. B, representative ThT fluorescence intensity trace for 5 μm TDP-43 LCD incubated without NaCl at pH 6, 25 °C (no LLPS). C, lag times derived from ThT fluorescence traces for LCD incubated in the absence of salt at pH 6, 25 °C, at varying protein concentrations. Error bars represent S.D. D, representative ThT fluorescence kinetic traces for 20 μm LCD incubated at pH 4 with various salt concentrations at 25 °C (each trace shown represents an average of three experiments). RFU, relative fluorescence units.
Because salt appears to be critical to inducing initial rapid oligomerization of the TDP-43 LCD in the absence of LLPS (see Fig. 2), next we investigated the impact of increasing ionic strength (higher salt concentration) on fibrillation of the protein. We performed these studies at pH 4 because a broader range of salt concentrations could be tested without inducing LLPS. In the absence of salt, no ThT fluorescence could be detected during the timescale of the experiment (up to 30 h). In contrast, we observed enhanced ThT fluorescence over time with diminishing lag times at increasing salt concentrations (Fig. 3D). Thus, the addition of salt under non-LLPS conditions appears to promote not only rapid formation of initial small oligomers but also the assembly of the TDP-43 LCD into amyloid fibrils.
TDP-43 fibrillation under phase separation conditions
Next, we turned our investigation to characterizing in greater detail the aggregation/fibrillation behavior of the protein under LLPS conditions. In addition to individual droplets, we observed relatively rapid formation (within ∼15–30 min) of beaded structures that appeared to result from partial fusion events and were deposited on the bottom of the microscope slide. This is exemplified in Fig. 4A for droplets formed at pH 7 and was also observed for LLPS at pH 4 and 6. Material properties of both droplet types were characterized by fluorescence recovery after photobleaching (FRAP), revealing a time-dependent decrease in maximal fluorescence recovery and rate of recovery (Fig. 4B). These results suggest a progression toward a gel-like, potentially aggregated state for both individual and beaded droplets.
Figure 4.
Formation of TDP-43 amyloid fibrils within liquid droplets. A, representative fluorescence microscopy images for FRAP experiments on individual droplets (left) and beaded droplets (right) prepared from 50 μm LCD and 100 nm Alexa Fluor 488–labeled LCD in pH 7 buffer with 300 mm NaCl. Scale bar, 5 μm. B, fluorescence recovery traces after photobleaching for experiments illustrated in A. Each trace represents an average of at least three droplets, and error bars represent standard deviation. C, atomic force microscopy images of TDP-43 LCD droplets deposited and dried on mica at various time points during incubation at 25 °C under LLPS conditions in a buffer containing 300 mm NaCl at pH 4 (upper images) or pH 6 (lower images). Protein concentration, 20 μm. White scale bars correspond to 400 nm. D, representative atomic force microscopy images of fibrils after prolonged (6-day) incubation of TDP-43 LCD under LLPS conditions at pH 4, 6, or 7 in the presence of 300 mm NaCl. Scale bars, 400 nm.
To more closely examine the nature of aggregates formed within droplets, we employed AFM imaging. Freshly prepared droplets deposited and dried on a mica surface appeared as large spherical enclosures containing smaller particles, most likely representing patches of dried protein. AFM images of droplets deposited after different periods of aging show time-dependent morphological changes. Importantly, after several hours of incubation, these images clearly demonstrate fibrils emanating directly from the droplets (Fig. 4C). After longer incubation, there is a gradual progression to mostly (if not exclusively) fibrillar structures with varying degrees of clumping, which appears to be particularly severe at neutral pH (Fig. 4D). Thus, these data demonstrate that the formation of amyloid fibrils can occur within liquid droplets.
Next, we sought to explore the kinetics of TDP-43 LCD aggregation under LLPS conditions and to relate this to aggregation under non-LLPS conditions. ThT fluorescence traces at pH 6 revealed rapid polymerization under robust LLPS (200–300 mm NaCl) conditions, with lag phases markedly shorter compared with those observed in the absence of LLPS (Fig. 5A). The growth phases under LLPS conditions were rather complex, involving an initial rapid increase in fluorescence followed by a secondary, slower rate of increase toward steady state. These rapid phases, which were completed within ∼3–3.5 h, corresponded to ∼35–50% of maximal fluorescence intensity increase. By contrast, the reaction in the absence of LLPS (no NaCl) required ∼10 h to reach the same ThT fluorescence response, further indicating a strong accelerating effect of LLPS on amyloid formation. It should be noted that Thioflavin-T is a rotor dye, and its fluorescence properties can change as a function of solvent viscosity (52). Because LLPS occurs almost instantaneously with detectable turbidity, whereas fluorescence response indicative of aggregation occurs after a substantial lag phase (at least 1–2 h), the present ThT data largely reflect the formation of amyloids as opposed to changes in viscosity related to LLPS. This is further confirmed by coincident AFM imaging depicting robust fibril growth.
Figure 5.

LLPS strongly accelerates fibrillation of TDP-43 LCD. A, ThT fluorescence traces for 20 μm LCD incubated at 25 °C in pH 6 buffer with various concentrations of NaCl. B, C, and D, lag phase time from ThT kinetic traces at pH 4 (B), 6 (C), and 7 (D) at various concentrations of NaCl. Protein concentration, 20 μm. E, lag phase time of fibrillation as a function of initial turbidity depicting data accumulated in this study at conditions of different pH and salt concentrations. Data in B–E represent averages from experiments using at least three separately prepared batches of protein. Protein concentration, 20 μm. Error bars represent S.D.
Because salt accelerates fibrillation in the absence of LLPS at pH 4, we anticipated that salt would further accelerate aggregation under LLPS conditions. Although the fastest aggregation occurred under LLPS conditions (300 mm NaCl), to our surprise, the most significant changes in lag phase still occurred at relatively low salt concentrations. The magnitude of these changes strongly diminished at higher salt concentrations (that still do not result in LLPS), and this apparent “saturation” persisted into the two-phase regime (300 mm NaCl) (Fig. 5B). A similar trend was observed for lag phases at pH 6 (Fig. 5C). In this case, however, even lower salt concentrations were sufficient to promote rapid fibrillation. We reasoned that this effect of salt on fibrillation kinetics may be related to pH-dependent changes in charge repulsion among TDP-43 LCD molecules (53). At pH 4, 6, and 7, the predicted net charge of our protein is +13.2, +9.6, and +6.4, respectively (calculated from protcalc.sourceforge.net).4 At higher pH, protein–protein interactions would be enhanced by a decreased net charge repulsion, thereby enabling faster aggregation and a diminished responsivity to salt (54). Indeed, at pH 7, salt appeared to have minimal effect on lag phase (Fig. 5D). We subsequently explored the relationship between lag phase and LLPS (as assessed by initial sample turbidity) and found that, regardless of salt concentration or pH, all reactions under LLPS conditions were characterized by a very short lag phase of ∼1–2 h (Fig. 5E).
Overall, these results demonstrate that electrostatic effects regulate both LLPS and fibrillation kinetics and that conditions fostering robust LLPS coincide with those facilitating faster amyloidogenesis. To parse out the exact role of LLPS on TDP-43 LCD fibrillation while controlling for the effect of salt, we utilized additional LLPS regulators. First, we employed 5% 1,6-hexanediol, a hydrophobic reagent known to inhibit formation of liquid droplets (36). Turbidity measurements performed at pH 6 in the presence of 200 mm NaCl clearly indicate that this reagent indeed almost completely abrogates LLPS under these conditions (Fig. 6A). Importantly, the lag phase of the fibrillation reaction in the presence of 5% 1,6-hexanediol was markedly increased (Fig. 6B), indicating that the conditions of LLPS per se promote faster fibrillation of the TDP-43 LCD. As expected, no change in lag time was observed under control non-LLPS conditions (pH 4, 200 mm NaCl).
Figure 6.

LLPS intrinsically promotes TDP-43 LCD fibrillation independently of electrostatic effects. Turbidity (A) and fibrillation lag phase time (B) for 20 μm protein at 25 °C in the presence or absence of 5% 1,6-hexanediol. Buffer conditions, pH 4, 200 mm NaCl (control, no LLPS with and without 5% 1,6-hexanediol) or pH 6, 200 mm NaCl (LLPS in the absence of 5% 1,6-hexanediol only). Turbidity (C) and fibrillation lag phase time (D) for 20 μm protein at either 25 or 37 °C. Buffer conditions, pH 4, 200 mm NaCl (control, no LLPS at both temperatures) or pH 6, 200 mm NaCl (LLPS at 25 °C only) (no 1,6-hexanediol was used). Error bars represent S.D.
As opposed to using 1,6-hexanediol to disrupt LLPS, in a second experiment, we took advantage of the temperature sensitivity of TDP-43 LCD LLPS at pH 6. Consistent with data in Fig. 1, elevation of temperature to 37 °C at pH 6 in the presence of 200 mm NaCl resulted in essentially complete inhibition of the LLPS that is observed under identical buffer conditions at 25 °C (Fig. 6C). Again, this abrogation of LLPS coincided with a substantial increase in the duration of the lag phase of fibrillation reaction at pH 6 (Fig. 6D). In contrast, the lag phase under control non-LLPS conditions (pH 4, 200 mm NaCl) was actually slightly shorter at 37 °C as compared with that at 25 °C, an expected outcome for nonphase-separating amyloidogenic proteins (55). Altogether, these data consistently point to a direct role of LLPS as a mechanism for promoting TDP-43 LCD polymerization into amyloid fibrils.
Discussion
A recent series of exciting studies has demonstrated that a number of aggregation-prone proteins involved in neurodegenerative diseases can undergo LLPS (56–58). For some (e.g. FUS and hnRNPA1), the droplet environment is quite conducive to amyloid formation (39–41). Among these LLPS-prone proteins, TDP-43 is of particular interest because its aggregation is associated with a host of neurodegenerative disorders, including ALS, frontotemporal dementia, chronic traumatic encephalopathy, and Alzheimer's disease (1, 3–5, 7). In the absence of LLPS, the TDP-43 LCD has recently been demonstrated to form amyloid fibrils (13); however, the mechanism of this process is poorly understood. An even more critical knowledge gap involves the connection between LLPS and the aggregation pathway of TDP-43. Insight into this relationship is of potentially crucial importance, as LLPS may play a regulatory role in the pathogenesis of neurodegenerative disorders. In the present study, we have expanded the current understanding of the conditions and interactions that regulate LLPS of the TDP-43 LCD in vitro and, on this background, explored the impact of LLPS on the aggregation behavior of the protein.
Initial work on the LLPS of the TDP-43 LCD focused on experiments around pH 6 and revealed that the addition of salt promotes liquid droplet formation (35–37). These findings emphasized the importance of unfavorable electrostatic repulsion that decreases the propensity for phase separation and of favorable hydrophobic interactions that are essential for droplet formation. Here, we show that pH and molecular crowding also play a regulatory role in LLPS, with the requirement for salt diminishing as pH approaches neutral values. These combined effects favor LLPS under physiologically relevant buffer conditions and protein concentrations. Importantly, our data also reveal that electrostatic repulsion is a pervasive regulatory element not only of phase separation but also of protein oligomerization and, eventually, the formation of amyloid fibrils. A previous study proposed that neutral pH is required for fibrillation of TDP-43 LCD (13). However, no kinetic curves were presented, and, in our experience with using a similar purification protocol, the 1 mm phosphate solution used in those biophysical experiments may not have sufficient capacity to buffer TFA salts present upon reconstitution of HPLC-purified protein. This apparent pH dependence was suggested to result from ostensible intramolecular hydrogen bond networks (between backbone amide protons and side-chain oxygen atoms) at acidic pH that would break down at more neutral pH, leading to faster fibrillation (13). However, as noted in a commentary on this study (53), the presence (and disruption by changes in pH) of such a network in the LCD is highly unlikely. Our present data that demonstrate a strong accelerating effect of salt on fibrillation kinetics provide direct experimental support to an alternative explanation (53), which argues that electrostatic repulsion (which diminishes at neutral pH or in the presence of salt) governs the pH dependence of TDP-43 LCD fibrillation.
Along the same line, we find that the same electrostatic repulsion that regulates LLPS and fibrillation of TDP-43 LCD is intrinsically linked to rapid formation of early (non-ThT–reactive) oligomers in the presence of salt. Oligomerization appears to be stabilized by intermolecular interactions that involve the same α-helical region that has been proposed to be important for LLPS (35, 36). The formation of multimers has been suggested previously based on weakening NMR signal intensities (13, 35, 36). Our present study provides more direct evidence for this reaction and reveals that it is regulated by electrostatic effects. Furthermore, our spin labeling/EPR experiments suggest that rapid oligomerization of TDP-43 LCD also occurs within the context of liquid droplets. Because oligomeric species would be expected to diffuse relatively slowly, our FRAP data indicate that droplets remain dynamic beyond the time period required for rapid protein oligomerization. This suggests that these initial oligomers might also have a dynamic character, allowing for rapid exchange of the monomers.
The key finding of our present investigation is that LLPS is highly conducive to the formation of amyloid fibrils by the TDP-43 LCD. The aggregative process under LLPS conditions appears to include several distinct stages whereby the initial events are characterized by relatively rapid self-association of the LCD into oligomeric species and subsequent changes in material properties within liquid droplets (as detected by loss of dynamicity via FRAP). These events are followed by the assembly of Thioflavin-T–reactive fibrillar aggregates. Although it was not a primary focus of the seminal work by Conicella et al. (35), who first characterized the LLPS of the TDP-43 LCD, ThT-reactive species were not observed to form within mature droplets. This suggested that aggregation under LLPS conditions may follow a nonamyloidogenic pathway. However, our present data clearly demonstrate that this is not the case. In fact, LLPS appears to promote the amyloidogenic pathway, as indicated by substantially faster overall fibrillation kinetics (and remarkably shorter lag times) as compared with those in the absence of LLPS. AFM imaging clearly depicts fibrils emanating from within droplets (Fig. 4C). The notion that LLPS facilitates TDP-43 LCD amyloidogenesis is further supported by experiments disrupting droplet formation (while controlling for changes in electrostatic repulsion) via elevated temperature or the addition of 1,6-hexanediol, both of which result in slower fibrillation. In contrast, in the absence of LLPS, higher temperatures instead appear to facilitate faster fibrillation, similar to the observations for other amyloidogenic proteins in bulk solution (55). Thus, LLPS is playing a regulatory role in pathological aggregation of TDP-43 LCD.
In contrast to fibrillation reactions in the absence of LLPS that depict classical polymerization kinetics, traces under LLPS conditions are far more complex. These are characterized by a lag phase that is followed by at least two distinct stages of ThT fluorescence increase associated with fibrillar growth (Fig. 5A). This is not surprising given that in a two-phase system the protein can aggregate both within liquid droplets and in the surrounding bulk solution. The first of these growth stages is very rapid, likely representing fibrillation occurring within droplets where the protein is highly concentrated. The origin and interpretation of the second, much slower growth phase are more complicated. This stage may represent contributions from both a spontaneous fibrillation reaction in the bulk solution and a reaction in the bulk solution that is seeded with fibrillar aggregates (that rapidly formed within the droplets). However, the efficiency of this seeding might not be very high because these droplet-associated fibrils appear to be highly clumped.
Our current findings regarding the impact of LLPS on the aggregation properties of TDP-43 are limited to experiments in vitro with a purified LCD. As such, these findings do not account for the potential role of the TDP-43 N-terminal domain, which may alter the aggregation landscape by modulating phase separation and the formation of pathogenic species (10, 17, 59, 60). It is likely that the reported recruitment of TDP-43 to cytoplasmic stress granules in vivo (61, 62) may involve similar self-association of TDP-43 molecules, thus triggering robust LLPS-mediated fibrillation. Indeed, the notion that LLPS may mediate formation of pathological aggregates of TDP-43 in neurodegenerative diseases is supported by recent observations that TDP-43 aggregates appear to localize to stress granules in Drosophila and mouse models of traumatic brain injury (63, 64). Consistent with these findings, our data suggest that LLPS plays a direct role in facilitating aggregation of the TDP-43 LCD, likely by providing an environment of increased local concentration of the protein. However, recent evidence from a cell culture model suggests that these aggregates eventually dissociate from stress granules (65). Detailed elucidation of the mechanisms of formation of these aggregates is of great importance not only for understanding the pathogenic process but also for developing therapeutic approaches. On this front, recent structural investigations of TDP-43 LCD peptides have revealed a labile, intermediary type of interaction (referred to as low-complexity aromatic-rich kinked segments, or LARKS) that may subsequently become irreversible (48). These types of interactions could be involved in the observed early changes in material properties of droplets during the lag phase of amyloid aggregation and would therefore be optimal for therapeutic intervention. Indeed, a chemical chaperone has recently been shown to promote LLPS of TDP-43 while abrogating amyloid formation, although aggregation within the context of liquid droplets was not directly examined in this study (66). Even though further studies are needed to fully understand the link between LLPS and TDP-43 aggregation in vivo, our findings ultimately posit that LLPS is a viable, biologically relevant mechanism under which the formation of amyloid aggregates by TDP-43 may occur and contribute to the pathogenicity of neurodegenerative disorders.
Experimental procedures
Expression, purification, and preparation of WT and Cys variants
The LCD sequence was subcloned into a pRSET-B vector from the full-length TDP-43, originally obtained as a gift from Aaron Gitler (Addgene plasmid 27462). The construct was designed to encode the LCD protein (residues 267–414) with an N-terminal His6 tag and thrombin cleavage site (MRGSHHHHHHLVPRGS). His tag removal consistently resulted in low yields of purified protein, possibly due to the high aggregation propensity at conditions necessary for efficacious thrombin activity. Although the presence of a histidine (with a pKa of ∼6) likely has an influence on the pH dependence of the LCD (which does not naturally contain histidine), use of a His-tagged protein is in line with almost all previously published studies exploring the LLPS or aggregation properties of purified TDP-43 LCD (13, 36, 67). A notable exception is the study by Conicella et al. (35) in which the authors removed the His tag but which still included artificial GH residues at the N terminus. However, in our experience, the recovery of the cleaved protein used in our present study (which would not contain the extra His residue) was very low. Therefore, we used His-tagged protein, which could then be purified in quantities sufficient for systematic biophysical studies.
Protein was expressed in BL21 (DE3) Escherichia coli overnight, and bacteria were lysed by sonication in Buffer A (20 mm Tris-HCl buffer, pH 8, containing 8 m urea, 500 mm NaCl, and 25 mm imidazole). Protein was purified on Ni-charged nitrilotriacetic acid column using 4–5 column volume washes with Buffer A and subsequent elution in Buffer B (20 mm Tris-HCl buffer, pH 8, containing 8 m urea, 200 mm NaCl, and 250 mm imidazole). This was followed by a final purification step by HPLC using a C4 column acetonitrile gradient in water containing 0.05% TFA. Purified protein (better than 95% purity as assessed by gel electrophoresis and MS) was flash frozen and lyophilized.
Single-Cys variants were generated by site-directed mutagenesis, expressed, and purified by Ni-charged nitrilotriacetic acid as described above but in the additional presence of 1 mm TCEP. Labeling of Cys variants was performed for 1–2 h in Buffer B (+1 mm TCEP) with >15-fold molar ratio of (1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl) methanethiosulfonate (MTSL; Toronto Research Chemicals) to protein (∼10 mg/ml LCD protein). Labeling efficiency was confirmed by MS. Free label was removed using 7-kDa-cutoff Zeba spin desalting columns equilibrated with Buffer C (20 mm Tris buffer, pH 8, containing 8 m urea and 150 mm NaCl) to maximize protein recovery. The final purification step involved HPLC as described above.
Alexa Fluor 488 fluorescently labeled protein was prepared by attaching Alexa Fluor 488 C5-maleimide (Thermo Fisher) to the protein variant with Cys at position 275. After labeling according to the manufacturer's instructions (in Buffer B containing 1 mm TCEP), excess label was removed by a spin desalting column equilibrated with Buffer C.
Immediately before experiments, lyophilized protein was dissolved in Milli-Q H2O (∼200–400 μl) and passed through a 0.5-ml 100-kDa Amicon Ultra centrifugal filter unit. Filtered protein was confirmed to be monomeric by dynamic light scattering, and its concentration was assessed by absorbance at 280 nm using an extinction coefficient of 17,990. The protein was then buffered to the appropriate pH using 10 mm sodium acetate (pH 4) or 10 mm potassium phosphate (pH 6 and 7).
Fluorescence microscopy and FRAP measurements
Bright field and fluorescence microscopy imaging studies for Fig. 1 only were acquired using a Keyence BZ-X700 microscope with 100×/1.45 oil immersion lens. The microscope uses a metal halide lamp, GFP filter cube (excitation, 470 nm; DM 495), monochrome charge-coupled device, and Nikon CF160 series infinite optical system. Fluorescence microscopy images were taken using a 1:200 molar ratio of Alexa Fluor 488–labeled to unlabeled protein. Processing of bright-field images involved a haze reduction filter to highlight identifiable, small species. Processing of fluorescence images involved black balance correction only.
FRAP was performed using a Leica SP8 confocal microscope with 2.4-milliwatt laser intensity for bleaching, 63×/1.4 oil immersion objective, and photomultiplier tube detector. Each FRAP experiment involved five prebleach frames followed by 10 bleach frames, and recovery was monitored over 300 s (one frame/5 s). Because multiple droplets could be observed in each frame, three droplets were bleached at a time for each experiment. FRAP analysis involved assessment of mean fluorescence intensity from each bleached region of interest as well as nonbleached regions of interest to correct for microscope drift. Individual FRAP traces were normalized to maximal prebleach and minimal postbleach intensities.
Turbidity and Thioflavin-T fluorescence assays
Turbidity (optical density at 600 nm) measurements were performed using an M1000 Tecan plate reader. The reported A600 values reflect initial turbidity at 25 °C or once the plate reached 37 °C. Kinetic traces for fibrillation were acquired by measuring ThT fluorescence (dye concentration of 15 μm) on the M1000 Tecan plate reader with excitation and emission wavelengths of 440 and 485 nm, respectively. Measurements were taken every 10 min with no additional agitation. Lag phases for aggregation reactions were quantified as the time point of intersection between a line drawn through the elongation phase data points and a line drawn through the lag phase data points (55).
EPR spectroscopy
EPR spectra were obtained at ambient temperature on a Bruker EMX spectrometer outfitted with a high-sensitivity resonator. The measurements were performed using field modulation of 2 G and a scan width of 200 G.
Circular dichroism spectroscopy
Spectra were recorded in a 1-mm-path-length quartz cuvette at 25 °C using an AVIV Model 215 spectrometer.
Dynamic light scattering
Measurements were performed in a disposable cuvette using a DynaPro NanoStar dynamic light scattering instrument (Wyatt Technology) at 25 °C (25 acquisitions per measurement with 5-s averaging time). Data were analyzed using built-in Dynamics software.
Atomic force microscopy imaging
Samples were deposited on freshly cleaved mica substrate, left at ambient temperature for ∼3–5 min, then washed four times with fresh Milli-Q H2O, and dried under N2. The images were obtained using scan assist mode and a silicon probe (spring constant, 40 newtons/m) on a Bruker multimode atomic force microscope equipped with Nanoscope V controller as described previously (68). Image processing was performed using Nanoscope Analysis software.
Author contributions
W. M. B. and W. K. S. conceptualization; W. M. B., R. H., and B. K. D. data curation; W. M. B., R. H., and B. K. D. formal analysis; W. M. B. and W. K. S. writing-original draft; W. M. B., R. H., and W. K. S. writing-review and editing; P. S., K. S., and W. K. S. methodology; K. S. and J.-K. C. resources; W. K. S. supervision; W. K. S. funding acquisition; W. K. S. validation; W. K. S. project administration.
Supplementary Material
Acknowledgment
We thank Sudha Chakrapani, Ph.D. for guidance in EPR experiments and manuscript revisions.
This work was supported by National Institutes of Health Grants F30 AG059350 (to W. M. B.), T32 NS077888, T32 GM 007250, P01 AI106705 (to W. K. S.), R01 NS103848 (to W. K. S.), and RF1 AG061797 (to W. K. S.). Microscopy work was supported by National Institutes of Health Office of Research Infrastructure Programs Grant S10 OD024996. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This article contains Figs. S1 and S2.
Please note that the JBC is not responsible for the long-term archiving and maintenance of this site or any other third party hosted site.
- TDP-43
- transactive response DNA-binding protein of 43 kDa
- LCD
- low-complexity domain
- CTF
- C-terminal fragment
- LLPS
- liquid–liquid phase separation
- SDSL
- site-directed spin labeling
- FRAP
- fluorescence recovery after photobleaching
- hnRNP
- heterogeneous nuclear ribonucleoprotein
- rH
- hydrodynamic radius
- AFM
- atomic force microscopy
- ThT
- Thioflavin-T
- TCEP
- tris(2-carboxyethyl)phosphine
- I
- intensity
- FUS
- fused in sarcoma
- hnRNPA1
- heterogeneous nuclear ribonucleoprotein A1.
References
- 1. Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., Bruce J., Schuck T., Grossman M., Clark C. M., McCluskey L. F., Miller B. L., Masliah E., Mackenzie I. R., Feldman H., et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133 10.1126/science.1134108 [DOI] [PubMed] [Google Scholar]
- 2. Al-Chalabi A., and Hardiman O. (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 9, 617–628 10.1038/nrneurol.2013.203 [DOI] [PubMed] [Google Scholar]
- 3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., and Oda T. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602–611 10.1016/j.bbrc.2006.10.093 [DOI] [PubMed] [Google Scholar]
- 4. Josephs K. A., Whitwell J. L., Weigand S. D., Murray M. E., Tosakulwong N., Liesinger A. M., Petrucelli L., Senjem M. L., Knopman D. S., Boeve B. F., Ivnik R. J., Smith G. E., Jack C. R. Jr., Parisi J. E., Petersen R. C., et al. (2014) TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol. 127, 811–824 10.1007/s00401-014-1269-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Josephs K. A., Murray M. E., Whitwell J. L., Tosakulwong N., Weigand S. D., Petrucelli L., Liesinger A. M., Petersen R. C., Parisi J. E., and Dickson D. W. (2016) Updated TDP-43 in Alzheimer's disease staging scheme. Acta Neuropathol. 131, 571–585 10.1007/s00401-016-1537-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Chang X. L., Tan M. S., Tan L., and Yu J. T. (2016) The Role of TDP-43 in Alzheimer's disease. Mol. Neurobiol. 53, 3349–3359 10.1007/s12035-015-9264-5 [DOI] [PubMed] [Google Scholar]
- 7. McKee A. C., Gavett B. E., Stern R. A., Nowinski C. J., Cantu R. C., Kowall N. W., Perl D. P., Hedley-Whyte E. T., Price B., Sullivan C., Morin P., Lee H.-S., Kubilus C. A., Daneshvar D. H., Wulff M., et al. (2010) TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 69, 918–929 10.1097/NEN.0b013e3181ee7d85 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Nelson P. T., Trojanowski J. Q., Abner E. L., Al-Janabi O. M., Jicha G. A., Schmitt F. A., Smith C. D., Fardo D. W., Wang W. X., Kryscio R. J., Neltner J. H., Kukull W. A., Cykowski M. D., Van Eldik L. J., and Ighodaro E. T. (2016) “New old pathologies”: AD, PART, and cerebral age-related TDP-43 with sclerosis. J. Neuropathol. Exp. Neurol. 75, 482–498 10.1093/jnen/nlw033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Mompeán M., Romano V., Pantoja-Uceda D., Stuani C., Baralle F. E., Buratti E., Laurents D. V. (2016) The TDP-43 N-terminal domain structure at high resolution. FEBS J. 283, 1242–1260 10.1111/febs.13651 [DOI] [PubMed] [Google Scholar]
- 10. Wang A., Conicella A. E., Schmidt H. B., Martin E. W., Rhoads S. N., Reeb A. N., Nourse A., Ramirez Montero D., Ryan V. H., Rohatgi R., Shewmaker F., Naik M. T., Mittag T., Ayala Y. M., and Fawzi N. L. (2018) A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 37, e97452 10.15252/embj.201797452 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Ou S. H., Wu F., Harrich D., García-Martínez L. F., and Gaynor R. B. (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584–3596 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Johnson B. S., Snead D., Lee J. J., McCaffery J. M., Shorter J., and Gitler A. D. (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329–20339 10.1074/jbc.M109.010264 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Lim L., Wei Y., Lu Y., and Song J. (2016) ALS-causing mutations significantly perturb the self-assembly and interaction with nucleic acid of the intrinsically disordered prion-like domain of TDP-43. PLoS Biol. 14, e1002338 10.1371/journal.pbio.1002338 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Igaz L. M., Kwong L. K., Xu Y., Truax A. C., Uryu K., Neumann M., Clark C. M., Elman L. B., Miller B. L., Grossman M., McCluskey L. F., Trojanowski J. Q., and Lee V. M. (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am. J. Pathol. 173, 182–194 10.2353/ajpath.2008.080003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Zhang Y.-J., Xu Y. F., Dickey C. A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D., and Petrucelli L. (2007) Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530–10534 10.1523/JNEUROSCI.3421-07.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Li Q., Yokoshi M., Okada H., and Kawahara Y. (2015) The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat. Commun. 6, 6183 10.1038/ncomms7183 [DOI] [PubMed] [Google Scholar]
- 17. McGurk L., Gomes E., Guo L., Shorter J., and Bonini N. (2018) Poly(ADP-ribose) engages the TDP-43 nuclear-localization sequence to regulate granulo-filamentous aggregation. Biochemistry 57, 6923–6926 10.1021/acs.biochem.8b00910 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Neumann M., Kwong L. K., Sampathu D. M., Trojanowski J. Q., and Lee V. M. (2007) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch. Neurol. 64, 1388–1394 10.1001/archneur.64.10.1388 [DOI] [PubMed] [Google Scholar]
- 19. Robinson J. L., Geser F., Stieber A., Umoh M., Kwong L. K., Van Deerlin V. M., Lee V. M., and Trojanowski J. Q. (2013) TDP-43 skeins show properties of amyloid in a subset of ALS cases. Acta Neuropathol. 125, 121–131 10.1007/s00401-012-1055-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Bigio E. H., Wu J. Y., Deng H.-X., Bit-Ivan E. N., Mao Q., Ganti R., Peterson M., Siddique N., Geula C., Siddique T., and Mesulam M. (2013) Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol. 125, 463–465 10.1007/s00401-013-1089-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Fatima M., Tan R., Halliday G. M., and Kril J. J. (2015) Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways. Acta Neuropathol. Commun. 3, 47 10.1186/s40478-015-0226-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Smethurst P., Sidle K. C., and Hardy J. (2015) Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS). Neuropathol. Appl. Neurobiol. 41, 578–597 10.1111/nan.12206 [DOI] [PubMed] [Google Scholar]
- 23. Braak H., Brettschneider J., Ludolph A. C., Lee V. M., Trojanowski J. Q., and Del Tredici K. (2013) Amyotrophic lateral sclerosis—a model of corticofugal axonal spread. Nat. Rev. Neurol. 9, 708–714 10.1038/nrneurol.2013.221 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Sekiguchi T., Kanouchi T., Shibuya K., Noto Y., Yagi Y., Inaba A., Abe K., Misawa S., Orimo S., Kobayashi T., Kamata T., Nakagawa M., Kuwabara S., Mizusawa H., and Yokota T. (2014) Spreading of amyotrophic lateral sclerosis lesions-multifocal hits and local propagation? J. Neurol. Neurosurg. Psychiatry 85, 85–91 10.1136/jnnp-2013-305617 [DOI] [PubMed] [Google Scholar]
- 25. Saini A., and Chauhan V. S. (2011) Delineation of the core aggregation sequences of TDP-43 C-terminal fragment. ChemBioChem 12, 2495–2501 10.1002/cbic.201100427 [DOI] [PubMed] [Google Scholar]
- 26. Mompeán M., Buratti E., Guarnaccia C., Brito R. M., Chakrabartty A., Baralle F. E., and Laurents D. V (2014) Structural characterization of the minimal segment of TDP-43 competent for aggregation. Arch. Biochem. Biophys. 545, 53–62 10.1016/j.abb.2014.01.007 [DOI] [PubMed] [Google Scholar]
- 27. Zhu L., Xu M., Yang M., Yang Y., Li Y., Deng J., Ruan L., Liu J., Du S., Liu X., Feng W., Fushimi K., Bigio E. H., Mesulam M., Wang C., and Wu J. Y. (2014) An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel-structure and induces TDP-43 redistribution. Hum. Mol. Genet. 23, 6863–6877 10.1093/hmg/ddu409 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Chen A. K., Lin R. Y., Hsieh E. Z., Tu P.-H., Chen R. P., Liao T.-Y., Chen W., Wang C.-H., and Huang J. J. (2010) Induction of amyloid fibrils by the C-terminal fragments of TDP-43 in amyotrophic lateral sclerosis. J. Am. Chem. Soc. 132, 1186–1187 10.1021/ja9066207 [DOI] [PubMed] [Google Scholar]
- 29. Liu G. C., Chen B. P., Ye N. T., Wang C.-H., Chen W., Lee H.-M., Chan S. I., and Huang J. J. (2013) Delineating the membrane-disrupting and seeding properties of the TDP-43 amyloidogenic core. Chem. Commun. 49, 11212–11214 10.1039/c3cc46762g [DOI] [PubMed] [Google Scholar]
- 30. Jiang L. L., Che M. X., Zhao J., Zhou C. J., Xie M. Y., Li H. Y., He J. H., and Hu H. Y. (2013) Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion. J. Biol. Chem. 288, 19614–19624 10.1074/jbc.M113.463828 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Jiang L.-L., Zhao J., Yin X.-F., He W.-T., Yang H., Che M.-X., and Hu H.-Y. (2016) Two mutations G335D and Q343R within the amyloidogenic core region of TDP-43 influence its aggregation and inclusion formation. Sci. Rep. 6, 23928 10.1038/srep23928 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Yang C., Tan W., Whittle C., Qiu L., Cao L., Akbarian S., and Xu Z. (2010) The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS One 5, e15878 10.1371/journal.pone.0015878 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Nonaka T., Kametani F., Arai T., Akiyama H., and Hasegawa M. (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 18, 3353–3364 10.1093/hmg/ddp275 [DOI] [PubMed] [Google Scholar]
- 34. Shimonaka S., Nonaka T., Suzuki G., Hisanaga S., and Hasegawa M. (2016) Templated aggregation of TAR DNA-binding protein of 43 kDa (TDP-43) by seeding with TDP-43 peptide fibrils. J. Biol. Chem. 291, 8896–8907 10.1074/jbc.M115.713552 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Conicella A. E., Zerze G. H., Mittal J., and Fawzi N. L. (2016) ALS mutations disrupt phase separation mediated by α-helical structure in the TDP-43 low-complexity C-terminal domain. Structure 24, 1537–1549 10.1016/j.str.2016.07.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Li H.-R., Chen T.-C., Hsiao C.-L., Shi L., Chou C.-Y., and Huang J. R. (2018) The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43. Biochim. Biophys. Acta Proteins Proteom. 1866, 214–223 10.1016/j.bbapap.2017.10.001 [DOI] [PubMed] [Google Scholar]
- 37. Li H.-R., Chiang W.-C., Chou P.-C., Wang W.-J., and Huang J. R. (2018) TAR DNA-binding protein 43 (TDP-43) liquid–liquid phase separation is mediated by just a few aromatic residues. J. Biol. Chem. 293, 6090–6098 10.1074/jbc.AC117.001037 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Sun Y., and Chakrabartty A. (2017) Phase to phase with TDP-43. Biochemistry 56, 809–823 10.1021/acs.biochem.6b01088 [DOI] [PubMed] [Google Scholar]
- 39. Patel A., Lee H. O., Jawerth L., Maharana S., Jahnel M., Hein M. Y., Stoynov S., Mahamid J., Saha S., Franzmann T. M., Pozniakovski A., Poser I., Maghelli N., Royer L. A., Weigert M., et al. (2015) A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162, 1066–1077 10.1016/j.cell.2015.07.047 [DOI] [PubMed] [Google Scholar]
- 40. Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A. P., Kim H. J., Mittag T., and Taylor J. P. (2015) Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123–133 10.1016/j.cell.2015.09.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Lin Y., Protter D. S., Rosen M. K., and Parker R. (2015) Formation and maturation of phase-separated liquid droplets by RNA-binding Proteins. Mol. Cell. 60, 208–219 10.1016/j.molcel.2015.08.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Zimmerman S. B., and Minton A. P. (1993) Macromolecular crowding: biochemical, biophysical, and physiological consequences. Annu. Rev. Biophys. Biomol. Struct. 22, 27–65 10.1146/annurev.bb.22.060193.000331 [DOI] [PubMed] [Google Scholar]
- 43. Wegmann S., Eftekharzadeh B., Tepper K., Zoltowska K. M., Bennett R. E., Dujardin S., Laskowski P. R., MacKenzie D., Kamath T., Commins C., Vanderburg C., Roe A. D., Fan Z., Molliex A. M., Hernandez-Vega A., et al. (2018) Tau protein liquid–liquid phase separation can initiate tau aggregation. EMBO J. 37, e98049 10.15252/embj.201798049 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Stoll S., and Schweiger A. (2007) Appendix 6. EasySpin: simulating CW ESR spectra. in ESR Spectroscopy in Membrane Biophysics (Hemminga M. A., and Berliner L. J., eds) Vol. 27, pp. 299–321, Springer, New York [Google Scholar]
- 45. Margittai M., and Langen R. (2008) Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: Molecular insights from electron paramagnetic resonance spectroscopy. Q. Rev. Biophys. 41, 265–297 10.1017/S0033583508004733 [DOI] [PubMed] [Google Scholar]
- 46. Francis D. J., Hubbell W. L., and Klug C. S. (2012) Probing protein secondary structure using EPR: investigating a dynamic region of visual arrestin. Appl. Magn. Reson. 43, 405–419 10.1007/s00723-012-0369-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Prasad A., Sivalingam V., Bharathi V., Girdhar A., and Patel B. K. (2018) The amyloidogenicity of a C-terminal region of TDP-43 implicated in Amyotrophic Lateral Sclerosis can be affected by anions, acetylation and homodimerization. Biochimie 150, 76–87 10.1016/j.biochi.2018.05.003 [DOI] [PubMed] [Google Scholar]
- 48. Guenther E. L., Cao Q., Trinh H., Lu J., Sawaya M. R., Cascio D., Boyer D. R., Rodriguez J. A., Hughes M. P., and Eisenberg D. S. (2018) Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol. 25, 463–471 10.1038/s41594-018-0064-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Harper J. D., and Lansbury P. T. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385–407 10.1146/annurev.biochem.66.1.385 [DOI] [PubMed] [Google Scholar]
- 50. Hortschansky P., Schroeckh V., Christopeit T., Zandomeneghi G., and Fändrich M. (2005) The aggregation kinetics of Alzheimer's β-amyloid peptide is controlled by stochastic nucleation. Protein Sci. 14, 1753–1759 10.1110/ps.041266605 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Stöhr J., Weinmann N., Wille H., Kaimann T., Nagel-Steger L., Birkmann E., Panza G., Prusiner S. B., Eigen M., and Riesner D. (2008) Mechanisms of prion protein assembly into amyloid. Proc. Natl. Acad. Sci. 105, 2409–2414 10.1073/pnas.0712036105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Stsiapura V. I., Maskevich A. A., Kuzmitsky V. A., Uversky V. N., Kuznetsova I. M., and Turoverov K. K. (2008) Thioflavin T as a molecular rotor: fluorescent properties of thioflavin T in solvents with different viscosity. J. Phys. Chem. B 112, 15893–15902 10.1021/jp805822c [DOI] [PubMed] [Google Scholar]
- 53. Mompeán M., Chakrabartty A., Buratti E., and Laurents D. V. (2016) Electrostatic repulsion governs TDP-43 C-terminal domain aggregation. PLos Biol. 14, e1002447 10.1371/journal.pbio.1002447 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Guo M., Gorman P. M., Rico M., Chakrabartty A., and Laurents D. V. (2005) Charge substitution shows that repulsive electrostatic interactions impede the oligomerization of Alzheimer amyloid peptides. FEBS Lett. 579, 3574–3578 10.1016/j.febslet.2005.05.036 [DOI] [PubMed] [Google Scholar]
- 55. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., Vyas S., Uversky V. N., and Fink A. L. (2001) Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40, 6036–6046 10.1021/bi002555c [DOI] [PubMed] [Google Scholar]
- 56. Elbaum-Garfinkle S., and Brangwynne C. P. (2015) Liquids, fibers, and gels: the many phases of neurodegeneration. Dev. Cell. 35, 531–532 10.1016/j.devcel.2015.11.014 [DOI] [PubMed] [Google Scholar]
- 57. St George-Hyslop P., Lin J. Q., Miyashita A., Phillips E. C., Qamar S., Randle S. J., and Wang G. (2018) The physiological and pathological biophysics of phase separation and gelation of RNA binding proteins in amyotrophic lateral sclerosis and fronto-temporal lobar degeneration. Brain Res. 1693, 11–23 10.1016/j.brainres.2018.04.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Aguzzi A., and Altmeyer M. (2016) Phase separation: linking cellular compartmentalization to disease. Trends Cell Biol. 26, 547–558 10.1016/j.tcb.2016.03.004 [DOI] [PubMed] [Google Scholar]
- 59. Afroz T., Hock E.-M., Ernst P., Foglieni C., Jambeau M., Gilhespy L. A. B., Laferriere F., Maniecka Z., Plückthun A., Mittl P., Paganetti P., Allain F. H. T., and Polymenidou M. (2017) Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 8, 45 10.1038/s41467-017-00062-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. McGurk L., Gomes E., Guo L., Mojsilovic-Petrovic J., Tran V., Kalb R. G., Shorter J., and Bonini N. M. (2018) Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol. Cell. 71, 703–717.e9 10.1016/j.molcel.2018.07.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Liu-Yesucevitz L., Lin A. Y., Ebata A., Boon J. Y., Reid W., Xu Y.-F., Kobrin K., Murphy G. J., Petrucelli L., and Wolozin B. (2014) ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J. Neurosci. 34, 4167–4174 10.1523/JNEUROSCI.2350-13.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Liu-Yesucevitz L., Bilgutay A., Zhang Y.-J., Vanderweyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., Sherman M., Petrucelli L., and Wolozin B. (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5, e13250 10.1371/journal.pone.0013250 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Anderson E. N., Gochenaur L., Singh A., Grant R., Patel K., Watkins S., Wu J. Y., and Pandey U. B. (2018) Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models. Hum. Mol. Genet. 27, 1366–1381 10.1093/hmg/ddy047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Wiesner D., Tar L., Linkus B., Chandrasekar A., Olde Heuvel F., Dupuis L., Tsao W., Wong P. C., Ludolph A., and Roselli F. (2018) Reversible induction of TDP-43 granules in cortical neurons after traumatic injury. Exp. Neurol. 299, 15–25 10.1016/j.expneurol.2017.09.011 [DOI] [PubMed] [Google Scholar]
- 65. Chen Y., and Cohen T. J. (January 10, 2019) Aggregation of the nucleic acid–binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation. J. Biol. Chem., in press 10.1074/jbc.RA118.006351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Choi K.-J., Tsoi P. S., Moosa M. M., Paulucci-Holthauzen A., Liao S. J., Ferreon J. C., and Ferreon A. C. M. (2018) A chemical chaperone decouples TDP-43 disordered domain phase separation from fibrillation. Biochemistry 57, 6822–6826 10.1021/acs.biochem.8b01051 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Wang L., Kang J., Lim L., Wei Y., and Song J. (2018) TDP-43 NTD can be induced while CTD is significantly enhanced by ssDNA to undergo liquid-liquid phase separation. Biochem. Biophys. Res. Commun. 499, 189–195 10.1016/j.bbrc.2018.03.121 [DOI] [PubMed] [Google Scholar]
- 68. Williams T. L., Choi J.-K., Surewicz K., and Surewicz W. K. (2015) Soluble prion protein binds isolated low molecular weight amyloid-β oligomers causing cytotoxicity inhibition. ACS Chem. Neurosci. 6, 1972–1980 10.1021/acschemneuro.5b00229 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




